Black Diamond Therapeutics Inc. (BDTX) Business Metric Overview - Stocknear

Black Diamond Therapeutic...

NASDAQ: BDTX · Real-Time Price · USD
2.94
0.07 (2.44%)
At close: Sep 05, 2025, 3:59 PM
2.94
0.00%
After-hours: Sep 05, 2025, 07:42 PM EDT

Black Diamond Therapeutics Revenue Breakdown

Period Ending Mar 31, 2025
Reportable Segment Revenue 70M
Reportable Segment Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selling, General, and Administrative Revenue 4.1M 4.96M 5.98M 5.22M 9.57M 6.7M 5.57M 7.86M 6.88M 6.81M 7.24M 6.28M 6.98M 7.89M 6.42M 7.74M 8M 7.89M 5.43M 5.55M 4.86M 5.53M 2.88M 2.51M 1.35M 828K 667K 708K 289.5K 289.5K
Selling, General, and Administrative Revenue Growth -17.39% -16.96% +14.61% -45.52% +42.87% +20.39% -29.17% +14.25% +1.03% -6.01% +15.39% -10.05% -11.59% +23.02% -17.08% -3.23% +1.30% +45.44% -2.23% +14.27% -12.07% +91.57% +14.72% +85.81% +63.41% +24.14% -5.79% +144.56% 0.00% n/a
Research and Development Revenue 9.32M 10.51M 12.3M 12.91M 12.47M 13.46M 15.2M 16.15M 13.15M 14.75M 14.61M 15.85M 16.2M 17.79M 19.66M 27.63M 26.72M 22.82M 17.76M 12.93M 10.17M 7.35M 7.46M 5.63M 5.65M 3.01M 2.38M 1.63M 1.47M 1.47M
Research and Development Revenue Growth -11.30% -14.56% -4.78% +3.56% -7.35% -11.47% -5.89% +22.81% -10.84% +0.99% -7.81% -2.15% -8.95% -9.55% -28.82% +3.39% +17.09% +28.52% +37.33% +27.13% +38.29% -1.42% +32.41% -0.21% +87.39% +26.65% +45.86% +10.95% 0.00% n/a